Dihydromyricetin alleviates methotrexate-induced hepatotoxicity via suppressing the ‎TLR4/NF-κB pathway and NLRP3 inflammasome/caspase 1 axis. - Matouk AI; Awad EM; El-Tahawy NFG; El-Sheikh AAK; Waz S (Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022)